News
Is Medtronic Stock a Buy Now?
Medtronic (NYSE: MDT) is on a roll in more than one way. The medical device giant is beating the S&P 500 since the start of 2023. The company also continues to strengthen its portfolios, winning
1 Soaring Growth Stock That's Still an Unbeatable Bargain
Are you looking for underappreciated growth stocks that can deliver big gains? Try starting your search in the rapidly growing industry for minimally invasive cosmetic procedures.
The global market
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
If you can buy high-quality dividend stocks when other investors sour on them, you can plant the seeds for robust returns in the future. And that's exactly why it might be worth buying shares of
Looking for Steady, Passive Income? Buy AbbVie Stock
Dividend growth investing revolves around selecting only the most reliable businesses for your portfolio. This can be measured by consecutive years of dividend growth.
With 51 consecutive years of
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
Illumina (NASDAQ: ILMN) and Bionano Genomics (NASDAQ: BNGO) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the
Why Illumina Fell 11.6% in April
Shares of Illumina (NASDAQ: ILMN) fell by 11.6% in April, according to data provided by S&P Global Market Intelligence.
The fall means that shares of the gene-sequencing company have only inched up
Why Illumina Fell 11.6% in April
Shares of Illumina (NASDAQ: ILMN) fell by 11.6% in April, according to data provided by S&P Global Market Intelligence.
The fall means that shares of the gene-sequencing company have only inched up
Why Illumina Fell 11.6% in April
Shares of Illumina (NASDAQ: ILMN) fell by 11.6% in April, according to data provided by S&P Global Market Intelligence.
The fall means that shares of the gene-sequencing company have only inched up
3 Great Income Stocks That Retirees Should Love
Most Americans don't have to wait until they're retired to know that Social Security benefits won't be enough to maintain their current lifestyle. If they pay any attention to retirement planning
Cigna Group (CI) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q1 2023 Earnings CallMay 05, 2023, 8:30 a.m. ET
Operator
Source Fool.com
2 Magnificent Dividend Stocks to Buy Before the Next Recession
Fears of a coming recession are probably about as high right now as they have been over the past year. That's because the U.S. Federal Reserve recently predicted an economic downturn would descend
2 Magnificent Dividend Stocks to Buy Before the Next Recession
Fears of a coming recession are probably about as high right now as they have been over the past year. That's because the U.S. Federal Reserve recently predicted an economic downturn would descend
2 Magnificent Dividend Stocks to Buy Before the Next Recession
Fears of a coming recession are probably about as high right now as they have been over the past year. That's because the U.S. Federal Reserve recently predicted an economic downturn would descend
Should You Buy Novocure Stock Right Now?
Going, going, gone? That could be the question that Novocure (NASDAQ: NVCR) investors are asking these days. Shares of the oncology company plunged 56% in 2021. The stock slid 2% lower last year
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc
Why Karyopharm Therapeutics Shares Slumped Thursday
Shares of Karyopharm Therapeutics (NASDAQ: KPTI) were down more than 26% Thursday afternoon after the biotech company released first-quarter earnings and updated its guidance. The stock fell to its
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
Pfizer (NYSE:PFE) confirmed this week what everyone has been expecting. COVID-19 vaccine sales are falling drastically. The company reported a 77% drop in Comirnaty sales in the first quarter
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
Pfizer (NYSE:PFE) confirmed this week what everyone has been expecting. COVID-19 vaccine sales are falling drastically. The company reported a 77% drop in Comirnaty sales in the first quarter
Why Regeneron Pharmaceuticals Stock Is Tanking Today
Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biotechnology company, is under heavy pressure today. Specifically, the biotech's stock was down by an unsightly 6.5% on heavy volume as of
Why Regeneron Pharmaceuticals Stock Is Tanking Today
Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biotechnology company, is under heavy pressure today. Specifically, the biotech's stock was down by an unsightly 6.5% on heavy volume as of
Why Regeneron Pharmaceuticals Stock Is Tanking Today
Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biotechnology company, is under heavy pressure today. Specifically, the biotech's stock was down by an unsightly 6.5% on heavy volume as of
Karyopharm Therapeutics (KPTI) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q1 2023 Earnings CallMay 04, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Zoetis (ZTS) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q1 2023 Earnings CallMay 04, 2023, 8:30 a.m. ET
Operator
Source Fool.com